简短正念冥想对血液透析患者抑郁和焦虑症状的初步可行性研究
这项随机对照试验在城市血液透析中心纳入41例有抑郁和/或焦虑症状的透析患者,评估8周椅旁正念冥想的可行性与效果。干预组71%完成研究且耐受良好,但抑郁(PHQ-9变化-3.0±3.9 vs -2.0±4.7,P=0.45)和焦虑(GAD-7变化-0.9±4.6 vs -0.8±4.8,P=0.91)评分均无统计学显著改善。
要点
- 血液透析患者中多达50%存在抑郁和/或焦虑症状,传统药物和心理治疗可及性不足。
- 简短椅旁正念冥想可行且耐受良好,但未显著改善抑郁或焦虑评分。
- 实施障碍包括透析班次频繁变动、员工或警报干扰、空间限制、病情波动和疲劳。
核心结论
- 正念冥想对血液透析伴抑郁和焦虑症状患者可行且耐受良好,但未显示对抑郁和焦虑评分的显著效果。
研究设计与样本
- 随机、对照、评估者盲法试验,在城市血液透析中心纳入41例患者,随机分为干预组(n=21)和常规治疗组(n=20)。
- 干预组接受8周个体椅旁冥想干预,每次10-15分钟,每周3次,在透析期间进行。
主要发现
- 符合条件者中67%入组(61例中41例);干预组71%完成研究,冥想耐受良好(Likert量表评分中位数8/10,四分位距10-5/10)。
- 干预组PHQ-9变化为-3.0±3.9,对照组为-2.0±4.7,P=0.45。
- 干预组GAD-7变化为-0.9±4.6,对照组为-0.8±4.8,P=0.91。
- 冥想与主观获益相关,但未显示统计学显著效果。
关键数值与推荐
- 可行性主要评估入组率、干预完成率和干预耐受性。
- 抑郁和焦虑症状分别使用PHQ-9和GAD-7测量。
临床怎么用
- 简短正念冥想可作为血液透析患者可耐受的辅助干预,但需注意实施障碍,且不应替代现有抑郁焦虑治疗。
局限性
- 本研究为初步可行性研究,样本量小(41例),可能不足以检测显著效应。
- 实施障碍包括透析班次频繁变动、员工或警报干扰、空间限制、参与者病情波动和疲劳。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Up to 50% of patients undergoing hemodialysis suffer from symptoms of depression and/or anxiety. Access to traditional pharmacotherapies and psychotherapies for depression or anxiety in this patient population has been inadequate. The objective of this study was to investigate the feasibility and effectiveness of brief mindfulness meditation intervention for patients on hemodialysis with depression and anxiety symptoms. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study was a randomized, controlled, assessor-blinded trial conducted in an urban hemodialysis unit. Forty-one patients were randomly assigned to intervention (n=21) and treatment-as-usual (n=20) groups. The intervention group received an 8-week individual chairside meditation intervention lasting 10-15 minutes, three times a week during hemodialysis. Feasibility outcomes were primarily assessed: enrollment rates, intervention completion rates, and intervention tolerability. Symptoms of depression and anxiety were measured using the Patient Health Questionnaire (PHQ-9) and the General Anxiety Disorder-7 (GAD-7). RESULTS: Of those deemed eligible for the study, 67% enrolled (41 of 61). Of the participants randomized to the intervention group, 71% completed the study, with meditation being well tolerated (median rating of 8 of 10 in a Likert scale; interquartile range=10-5 of 10). Barriers to intervention delivery included frequent hemodialysis shift changes, interruptions by staff or alarms, space constraints, fluctuating participant medical status, and participant fatigue. Meditation was associated with subjective benefits but no statistically significant effect on depression scores (change in PHQ-9, -3.0±3.9 in the intervention group versus -2.0±4.7 in controls; P=0.45) or anxiety scores (change in GAD-7, -0.9±4.6 versus -0.8±4.8; P=0.91). CONCLUSIONS: On the basis of the results of this study, mindfulness meditation appears to be feasible and well tolerated in patients on hemodialysis with anxiety and depression symptoms. The study did not reveal significant effects of the interventions on depression and anxiety scores. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2017_10_12_CJASNPodcast_17_12_.mp3.
引用
- Thomas Z, Novak M, Platas SGT, et al. Brief Mindfulness Meditation for Depression and Anxiety Symptoms in Patients Undergoing Hemodialysis: A Pilot Feasibility Study. Clin J Am Soc Nephrol. 2017. PMID: 29025788. doi:10.2215/CJN.03900417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。